Literature DB >> 27591238

Childless women's beliefs and knowledge about oocyte freezing for social and medical reasons.

J C Daniluk1, E Koert2.   

Abstract

STUDY QUESTION: What factors inform a woman's decision-making about oocyte freezing to preserve fertility for social and medical reasons? SUMMARY ANSWER: Women lacked knowledge about the costs and viability of oocyte freezing as a fertility preservation option for social and medical reasons, and identified health consequences, costs, and viability as being particularly influential in their decision-making. WHAT IS KNOWN ALREADY: Having only recently become a viable fertility preservation option, relatively little is known about childless women's beliefs or knowledge about oocyte freezing for social or medical reasons. STUDY DESIGN, SIZE, DURATION: A cross sectional study of 500 childless women was conducted in August, 2015. PARTICIPANTS/MATERIALS, SETTING,
METHODS: A total of 500 childless, presumed fertile, women from 18 to 38 years of age completed an online, self-report questionnaire assessing beliefs and knowledge about oocyte freezing to preserve fertility for social or medical reasons. MAIN RESULTS AND THE ROLE OF CHANCE: Financial costs (85.6%), health risks to themselves (86.4%) or their offspring (87.8%), and success rates (82%) were the primary factors that women felt would influence their decision to freeze their oocytes. Partner's feelings (88.6%), prognosis for a full recovery (85.4%), and concerns about the health effects of the hormones or oocyte retrieval procedure (85.4%) were identified as being particularly important when considering oocyte freezing for medical reasons. Consistent with their perceptions of having little or no knowledge about oocyte freezing, there was an overall correct response rate of 33% to the 12 knowledge questions. LIMITATIONS, REASONS FOR CAUTION: The online format and use of a survey company to recruit participants may have increased the risk of self-selection bias and limit the generalizability of these findings. The findings may also be limited by the fact that the participants were not facing cancer treatments, and the younger participants were not nearing the end of their reproductive lifespan, and therefore would not have had reason to learn about, or consider, fertility preservation for medical or social reasons. WIDER IMPLICATIONS OF THE
FINDINGS: Given the worldwide trend towards delaying childbearing and the increasing availability of oocyte freezing as an option to preserve women's fertility, it is likely these results could be extended to wider North American, European, and Australasian populations of English speaking childless women. STUDY FUNDING/COMPETING INTERESTS: No specific funding. No competing interests.
© The Author 2016. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  delayed childbearing; fertility awareness; fertility knowledge; fertility preservation; oocyte freezing

Mesh:

Year:  2016        PMID: 27591238     DOI: 10.1093/humrep/dew189

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  15 in total

1.  From artefactual to artificial intelligence-meeting the needs of ART patients and practitioners.

Authors:  David F Albertini
Journal:  J Assist Reprod Genet       Date:  2018-09       Impact factor: 3.412

2.  Assessing reproductive choices of women and the likelihood of oocyte cryopreservation in the era of elective oocyte freezing.

Authors:  Lauren W Milman; Suneeta Senapati; Mary D Sammel; Katherine D Cameron; Clarisa Gracia
Journal:  Fertil Steril       Date:  2017-05       Impact factor: 7.329

3.  Medical and elective fertility preservation: impact of removal of the experimental label from oocyte cryopreservation.

Authors:  Samantha B Schon; Maren Shapiro; Clarisa Gracia; Suneeta Senapati
Journal:  J Assist Reprod Genet       Date:  2017-06-27       Impact factor: 3.412

4.  Fertility awareness and attitudes among resident physicians across different specialties.

Authors:  Shelun Tsai; Tracy Truong; Jennifer L Eaton
Journal:  J Assist Reprod Genet       Date:  2022-02-07       Impact factor: 3.412

5.  Attitudes towards Social Oocyte Freezing from a Socio-cultural Perspective.

Authors:  Maren Schick; Réka Sexty; Beate Ditzen; Tewes Wischmann
Journal:  Geburtshilfe Frauenheilkd       Date:  2017-07-17       Impact factor: 2.915

Review 6.  New concepts for an old problem: the diagnosis of endometrial hyperplasia.

Authors:  Peter A Sanderson; Hilary O D Critchley; Alistair R W Williams; Mark J Arends; Philippa T K Saunders
Journal:  Hum Reprod Update       Date:  2017-03-01       Impact factor: 15.610

7.  Egg freezing for fertility preservation and family planning: a nationwide survey of US Obstetrics and Gynecology residents.

Authors:  Navid Esfandiari; Julia Litzky; Joshua Sayler; Pavel Zagadailov; Karen George; Leslie DeMars
Journal:  Reprod Biol Endocrinol       Date:  2019-01-29       Impact factor: 5.211

8.  A survey on the awareness and knowledge about elective oocyte cryopreservation among unmarried women of reproductive age visiting a private fertility center.

Authors:  Yeon Hee Hong; Jeong Woo Park; Hyein Kim; Seul Ki Kim; Chang Woo Choo; Byung Chul Jee; Chang Suk Suh; Seok Hyun Kim
Journal:  Obstet Gynecol Sci       Date:  2019-10-18

9.  Influence of Negative Emotional Expressions on the Outcomes of Shared Decision Making During Oncofertility Consultations in Japan.

Authors:  Tomoe Koizumi; Kazuko Nara; Tomoko Hashimoto; Satoru Takamizawa; Kouhei Sugimoto; Nao Suzuki; Yoshiharu Morimoto
Journal:  J Adolesc Young Adult Oncol       Date:  2018-07-23       Impact factor: 2.223

10.  Employee benefit or occupational hazard? How employer coverage of egg freezing impacts reproductive decisions of graduate students.

Authors:  Eden R Cardozo; Jenna M Turocy; Kaitlyn E James; Marlene P Freeman; Thomas L Toth
Journal:  F S Rep       Date:  2020-09-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.